PFA was noninferior to cryoablation for first recurrence of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation. Tissue-selective energy delivery and short application times offer ...

DEAR DR. ROACH: I’m a 67-year-old man who developed typical atrial flutter two years ago, but I haven’t had any symptoms that I am aware of. I don’t have a history of heart problems. My heart rate was ...

Visit Vektor Medical at Booth 208 to Learn More about vMap®, the VITAL-EP Registry’s AF Findings, and the Newly Released Atrial Flutter Workflow At this year’s meeting, a featured study titled "High ...

STATEN ISLAND, N.Y. — Northwell Staten Island University Hospital is among the first in the country to successfully treat persistent atrial fibrillation and typical atrial flutter using a ...

For comparison, a US study published in 2009, a year after the current study commenced, reported that the rate of catheter ablation in AF patients increased from 0.06% in 1990 to 0.79% in 2005. The ...

Q: I’m a 67-year-old man who developed typical atrial flutter two years ago, but I haven’t had any symptoms that I am aware of. I don’t have a history of heart problems. My heart rate was 117 bpm ...

Atrial fibrillation is a chronic, progressive disorder, and persistent forms of atrial fibrillation are associated with increased risks of thromboembolism and heart failure. Catheter ablation as ...

Please provide your email address to receive an email when new articles are posted on . A trial of a gold-tipped contact force-sensing catheter for treatment of patients with atrial flutter met its ...

Irregular heart rhythms, such as atrial fibrillation and atrial flutter, affect millions of Americans and can increase the risk of serious complications if left untreated. Understanding the warning ...

Vektor Medical to Showcase VITAL-EP Registry’s Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities Visit Vektor Medical at Booth 208 to ...

BOSTON--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, ...